The impact of the human DNA topoisomerse II C-terminal domain on activity

PLoS ONE

Volumn 3, Issue 3, 2008, Pages

  Meczes, Emma L ^a   Gilroy, Kathryn L ^a   West, Katherine L ^b   Austin, Caroline A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); ISOENZYME;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMERA; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME DEGRADATION; ENZYME LOCALIZATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN DOMAIN; REGULATORY MECHANISM; YEAST; CHEMISTRY; GENETIC COMPLEMENTATION; GENETICS; HUMAN; HYDROLYSIS; METABOLISM; PHOSPHORYLATION; PLASMID;

DNA TOPOISOMERASES, TYPE II; GENETIC COMPLEMENTATION TEST; HUMANS; HYDROLYSIS; PHOSPHORYLATION; PLASMIDS;

EID: 46149091732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001754     Document Type: Article

References (43)

1. Corbett KD, Berger JM (2004) Structure, Molecular Mechanisms and Evolutionary Relationships in DNA Topoisomerases. Amin Rev Biophys Biomol Struct 33: 95-118.
2. Ju B-G, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, et al. (2006) A Topoisomerase IIβ-Mediated dsDNA Break Required for Regulated Transcription. Science 312: 1798-1802.
3. Kitagawa H, Fujiki R, Yoshimura K, Mezaki Y, Uematsu Y, et al. (2003) The chromatin-remodelling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113: 905-917.
4. Ju B-G, Solum D, Song EJ, Lee K-J, Rose DW, et al. (2004) Activating the PARP-1 sensor component of the groucho/TLEI corepressor complex mediates a CaMKinaseIIdelta-dependent neurogenic gene activation pathway. Cell 119: 815-829.
5. Austin CA, Marsh KL, (1998) Eukaryotic DNA topoisomerase IIβ. Bioessays. 20: 215-226.
6. Wells NJ, Fry AM, Guano F, Norbury C, Hickson ID (1995) Cell cycle phase-specific phosphorylation of human topoisomerase II alpha: Evidence of a role for protein kinase C. J. Biol. Chem. 270: 28357-28363.
7. Cardenas ME, Dong Q, Glover CVC, Gasser SM (1992) Casein kinase II phosphorylates the eukaryotic-specific C-terminal domain of topoisonterase II in vivo. The EMBO J 11: 1785-1796.
8. Wells NJ, Addison CM, Fry AM, Ganapathi R, Hickson ID (1994) Scrine 1524 Is a Major Site of Phosphorylation on Human Topoisomerase Ilα Protein in vivo and is a Substrate for Casein Kinase II in vitro. J Biol Chem 269: 29746-29751.
9. Ishida R, Takashima R, Koujin T, Shibata M, Nozaki N, et al. (2001) Mitotic Specific Phosphorylation of Serine-1212 in Human DNA Topoisomerase Ilα. Cell Struct Func 26: 215-226.
10. Heck MMS, Hittelman WN, Earnshaw WC (1989) In vivo phosphorylation of the 170 kDa Form of Eukaryotic DNA Topoisomerase II: Cell Cycle Analysis. J Biol Chem 264: 15161-15164.
11. Escargueil AE, Plisov SY, Cochet C, Larsen AK (2000) Mitotic Phosphorylation of DNA Topoisomerase IIα by Protein Kinase CK2 Creates the MPM-2 Phosphoepitope on Ser-1469. J Biol Chem 275: 34710-34718.
12. Daum JR, Gorbsky GJ (1998) Casein Kinase II Catalyses a Mitotic Phosphorylation on Threonine 1342 of Human DNA Topoisomerase IIα, Which Is Recognised by the 3F3/2 Phosphoepitope Antibody.J Biol Chem 273: 30622-30629.
13. Ishida A, Iwai M, Marsh KL, Austin CA, Yano T, et al. (1996) Threonine 1342 in Human Topoisomerase IIα Is Phosphorylated Throughout the Cell Cycle. J Biol Chem 271: 30077-30082.
14. Bachant J, Akasabas A, Blat Y, Kleckner N, Elledge SJ (2002) The SUMO-1 Isopeptidase Smt4 is Linked to Centromeric Cohesion through SUMO-1 Modification of DNA Topoisomerase II. Mol Cell 9: 1169-1182.
15. Takahashi Y, Yong-Gonzalez V, Kikuchi Y, Strunnikov A (2006) SIZ1/SIZ2 Control of Chromosome Transmission Fidelity Is Mediated by the Sumoylation of Topoisomerase II. Genetics 172: 783-794.
16. Mao Y, Desai SD, Liu LF (2000) SUMO-1 Conjugation to Human DNA Topoisomerase II Isozymes. J Biol Chem 275: 26066-26073.
17. Azuma Y, Arnaoutov A, Dasso M (2003) SUMO-2/3 regulates topoisomerase II in mitosis. J Cell Biol 163: 477-487.
18. Isik S, Sarin K, Tsutsui K, Seki M, Enomoto T, et al. (2003) The SUMO pathway is required for selective degradation of DNA topoisomerase IIβ induced by a catalytic inhibitor ICRF-193. FEBS Lett 546: 374-378.
19. Mirski SEL, Gerlach JH, Cummings HJ, Zirngibl R, Greer PA, et al. (1997) Bipartite Nuclear Localisation Signals in the C-terminus of Human Topoisomerase IIα. Exp Cell Res 237: 452-455.
20. Mirski SE, Gerlach JH, Cole SP (1999) Sequence determinants of nuclear localisation in the alpha and beta isoforms of human topoisomerase II. Exp. Cell Res. 251: 329-339.
21. Wessel I, Jensen PB, Falck J, Mirski SEL, Cole SPC, et al. (1997) Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-Terminal region of topoisomerase IIα in Human Small Cell Lung Cancer cells selected for resistance to etoposide results in extranuclear enzyme localisation. Cancer Res 57: 4451-4454.
22. Cowell IG, Willmore E, Chalton D, Marsh KL, Jazrawi E, et al. (1998) Nuclear distribution of human DNA topoisomerase IIbeta: a nuclear targeting signal resides in the 116-residue C-terminal tail. Exp. Cell Res. 243: 232-240.
23. Sakaguchi A, Akashi T, Kikuchi A (2001) A distinct subcellular localisation of mammalian DNA topoisomerase IIbeta in yeast. Biochem. Biophys. Res. Comm. 283: 876-882.
24. Mirski SE, Bielawski JC, Cole SP (2003) Identification of functional nuclear export sequences in human topoisomerase II alpha and beta. Biochem. Biophys. Res. Commum. 306: 905-911.
25. Turner JG, Engel R, Derderian JA, Jove R, Sullivan DM (2004) Human topoisomerase IIa nuclear export is mediated by two CRM-1-dependent nuclear export signals. J Cell Sci 117: 3061-3071.
26. Adachi N, Miyaike M, Kato S, Kanamaru, R, Koyama H, et al. (1997) Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain. Nucleic Acids Res. 25: 3135-3142.
27. Linka RM, Porter AC, Volkov A, Mielke C, Boege F, et al. (2007) C-terminal regions of topoisomerase IIalpha and IIbeta determine isoforms-specific functioning of the enzymes in vivo. Nucleic Acids Res. 35: 810-822.
28. Austin CA, Marsh KL, Wasserman RA, Willmore E, Sayer PJ, et al. (1995) Expression, Domain Structure and Enzymatic Properties of an Active Recombinant Human DNA Topoisomerase IIβ. J. Biol. Chem. 270: 15739-15746.
29. Gilroy KL, Leontiou C, Padget K, Lakey JH, Austin CA (2006) mAMSA resistant human topoisomerase IIβ mutation G465D has reduced ATP hydrolysis activity. Nucleic Acid Res. 34: 1597-1607.
30. Leontiou C, Lakey JH, Austin CA (2004) Mutation E522K in Human DNA Topoisomerase IIβ Confers Resistance to Methyl N-(4′-(9-acridinylamino)-phenyl)carbamate hydrochloride and Methyl N-(4′-(9-acridinylamino)-3-me-thoxy-phenyl)methane sulfonamide but Hypersensitivity to Etoposide. Mol. Pharm. 66: 430-439.
31. Wasserman RA, Austin CA, Fisher LM, Wang JC (1993) Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast. Cancer Res 53: 3591-3596.
32. Meczes EL (1998) PhD Thesis.
33. Meczes EL, Marsh KL, Fisher LM, Rogers MP, Austin CA (1997) Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2β construct allows the study of topoisomerase IIβ inhibitors in yeast. Cancer Chemother. Pharmacol. 39: 367-375.
34. West KL, Turnbull RM, Willmore E, Lakey JH, Austin CA (2002) Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase IIβ: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability. Nucleic Acids Res. 30: 5416-5424.
35. Dickey JS, Oshcroff N (2005) Impact of the C-Terminal Domain of Topoisomerase IIα on the DNA Cleavage Activity of the Human Enzyme. Biochemistry 44: 11546-11554.
36. Jensen S, Andersen AH, Kjeldsen E, Biersack H, Olsen EHN, et al. (1996) Analysis of Functional Domain Organization in Topoisomerase II from Humans and Saccharomyces cerevisiae. Mol. Cell Biol. 16: 3866-3877.
37. McClendon AK, Rodriguez AC, Osheroff N (2005) Human topoisomerase IIalpha rapidly relaxes positively supercoiled DNA: implications for enzyme action ahead of replication forks. J. Biol. Chem. 280: 39337-39345.
38. Caron PR, Watt P, Wang JC (1994) The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II. Mol. Cell. Biol. 14: 3197-3207.
39. Shiozaki K, Yanagida M (1992) Functional dissection of the phosphorylated termini of fission yeast DNA topoisomerase II. J. Cell Biol. 119: 1023-1036.
40. Greenwood Grenshaw D, Hsieh T-S (1993) Function of the Hydrophilic Carboxyl Terminus of Type II DNA Topoisomerase from Drosophila melanogaster: I In Vitro Studies. J. Biol. Chem. 268: 21328-21334.
41. Sengupta T, Mukherjee M, Das R, Das A, Majunider HK (2005) Characterisation of the DNA-binding domain and identification of the active site residue in the 'GyrA' half of Leishmania donovani topoisomerase II. Nucleic Acids Res. 33: 2364-2373.
42. Marsh KL, Willmore E, Tinelli S, Cornarotti M, Meczes EL, et al. (1996) Amsacrine-Promoted DNA Cleavage Site Determinants for the Two Human DNA Topoisomerase II Isoforms α and β. Biochem. Pharmacol. 52: 16 75-1685.
43. Gilroy KL (2007) PhD Thesis.